Back-to-back regulatory approvals send Durham drugmaker's stock soaring

A rapid series of regulatory approvals has a Durham-based drugmaker's stock soaring – recovering from a sharp drop last year.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news